[4-[(4-amino-1-naphthalen-2-ylpyrazol-3-yl)carbamoyl]phenyl]methyl N-(pyridin-3-ylmethyl)carbamate
C28H24N6O3 — CID 91202922
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-[(4-amino-1-naphthalen-2-ylpyrazol-3-yl)carbamoyl]phenyl]methyl N-(pyridin-3-ylmethyl)carbamate
[4-[(4-amino-1-naphthalen-2-ylpyrazol-3-yl)carbamoyl]phenyl]methyl N-(pyridin-3-ylmethyl)carbamate (PubChem CID 91202922) has the molecular formula C28H24N6O3 and a molecular weight of 492.54 g/mol. Its IUPAC name is [4-[(4-amino-1-naphthalen-2-ylpyrazol-3-yl)carbamoyl]phenyl]methyl N-(pyridin-3-ylmethyl)carbamate.
Molecular Properties
| Compound Name | [4-[(4-amino-1-naphthalen-2-ylpyrazol-3-yl)carbamoyl]phenyl]methyl N-(pyridin-3-ylmethyl)carbamate |
|---|---|
| PubChem CID | 91202922 |
| Molecular Formula | C28H24N6O3 |
| Molecular Weight | 492.54 g/mol |
| Exact Mass | 492.19 |
| IUPAC Name | [4-[(4-amino-1-naphthalen-2-ylpyrazol-3-yl)carbamoyl]phenyl]methyl N-(pyridin-3-ylmethyl)carbamate |
| SMILES | Nc1cn(-c2ccc3ccccc3c2)nc1NC(=O)c1ccc(COC(=O)NCc2cccnc2)cc1 |
| InChI | InChI=1S/C28H24N6O3/c29-25-17-34(24-12-11-21-5-1-2-6-23(21)14-24)33-26(25)32-27(35)22-9-7-19(8-10-22)18-37-28(36)31-16-20-4-3-13-30-15-20/h1-15,17H,16,18,29H2,(H,31,36)(H,32,33,35) |
| InChIKey | AATWQPBGMARLNS-UHFFFAOYSA-N |
| XLogP | 4.68 |
| TPSA | 124.16 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 492.54 |
| LogP ≤ 5 | 4.68 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 91202922 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.